Initiating aggressive treatment within 3 months of symptom onset was crucial to patients with new-onset rheumatoid arthr

Women with rheumatoid arthritis (RA) being treated with methotrexate had no increase in the rate of induced abortions de

Patients with rheumatoid arthritis (RA) have an increased incidence of diastolic dysfunction, which may further raise th

It’s no Harry Potter fantasy – scientists have created a drug that goes into stealth mode to better target inflammation,

Treatment with oral tofacitinib (Xeljanz) inhibited structural progression and joint damage in patients with rheumatoid

A day after the new rheumatoid arthritis drug Xeljanz was reported to slow the progression of RA, a study published in t

An oral drug for rheumatoid arthritis that was approved by the FDA last year continues to show encouraging signs, even i

Adding the B-cell depleting agent rituximab (Rituxan) to methotrexate slowed joint damage progression in patients with r

Patients with later-onset rheumatoid arthritis (RA) may be receiving less effective treatment than their younger counter

As disease-modifying tumor necrosis factor (TNF) inhibitor use increases, the number of rheumatoid arthritis patients wh

The oral Janus kinase (JAK) inhibitor tofacitinib provided symptomatic benefits and improved physical function in patien

Treatment with methotrexate, the cornerstone disease-modifying therapy in rheumatoid arthritis, had no benefit on synovi

The interleukin-6 receptor blocker tocilizumab (Actemra) was significantly more effective as sole treatment for rheumato

Workers with rheumatoid arthritis have higher health care and other costs for U.S. employers than workers without the co

Before agreeing on specific tests, procedures or treatments, rheumatologists and patients need to be aware of the top fi

In what researchers are calling a first, a new analysis suggests that the greater a womans exposure to a type of common

Most rheumatoid arthritis patients with established disease who achieve a state of low disease activity while taking eta

Treatment with biologic response modifiers did not predispose patients with rheumatoid arthritis (RA) to an increased ri

Patients with rheumatoid arthritis (RA) are receiving the recommended cancer screening tests, but the recommendations ma

Industry funding doesnt appear to boost the likelihood of positive outcomes among published studies of drugs for rheumat